These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2578158)

  • 41. Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.
    Roszman TL; Brooks WH; Steele C; Elliott LH
    J Immunol; 1985 Mar; 134(3):1545-50. PubMed ID: 3155771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.
    Uchiyama T; Nelson DL; Fleisher TA; Waldmann TA
    J Immunol; 1981 Apr; 126(4):1398-403. PubMed ID: 6451645
    [No Abstract]   [Full Text] [Related]  

  • 44. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
    Kaplan J; Shope TC
    Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of altered membrane structure on NK cell-mediated cytotoxicity. III. Decreased susceptibility to natural killer cytotoxic factor (NKCF) and suppression of NKCF release by membrane rigidification.
    Roozemond RC; Mevissen M; Urli DC; Bonavida B
    J Immunol; 1987 Sep; 139(5):1739-46. PubMed ID: 3624869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-activated NK cells trigger monocyte oxidative metabolism.
    Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
    J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of the B lymphocyte response to pokeweed mitogen.
    Schreck C; Lamberson H; Davey F
    Ann Clin Lab Sci; 1982; 12(6):455-62. PubMed ID: 6983852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
    Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody potential of human peripheral blood lymphocytes differentially expressing surface membrane IgM.
    Thiele CJ; Stevens RH
    J Immunol; 1980 Apr; 124(4):1898-904. PubMed ID: 6767777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preferential elimination of NK and CTL functions by anti-D44 monoclonal antibody.
    Calvo CF; Boumsell L; Kolb JP; Laffy B; Bernard A; Senik A
    J Immunol; 1984 May; 132(5):2345-9. PubMed ID: 6232316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression by thymosin of pokeweed mitogen-induced differentiation of human B cells.
    Wolf RE; Goldstein AL; Ziff M
    Clin Immunol Immunopathol; 1978 Nov; 11(3):303-6. PubMed ID: 309373
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.
    Perussia B; Starr S; Abraham S; Fanning V; Trinchieri G
    J Immunol; 1983 May; 130(5):2133-41. PubMed ID: 6833758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of human B cell immunoglobulin secretion by the C3b component of complement.
    Tsokos GC; Berger M; Balow JE
    J Immunol; 1984 Feb; 132(2):622-6. PubMed ID: 6228593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural killer cells do not lyse resting or mitogen-stimulated B cells.
    Froelich CJ; Guiffaut S
    Nat Immun Cell Growth Regul; 1987; 6(1):12-8. PubMed ID: 3494907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes.
    Main EK; Lampson LA; Hart MK; Kornbluth J; Wilson DB
    J Immunol; 1985 Jul; 135(1):242-6. PubMed ID: 3158702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Production of antibody by human B cells under serum-free conditions.
    Farrant J; Newton CA; North ME; Weyman C; Brenner MK
    J Immunol Methods; 1984 Mar; 68(1-2):25-34. PubMed ID: 6608557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.